Reconstitution volumes that produce round numbers, tabulated

Reconstitution volumes that produce round numbers, tabulated — setting out what I have, and where I think it stops being reliable.

Writing this out with the numbers in it, because "roughly" is how these go wrong.

Vial: 10 mg of tirzepatide. Diluent added: 1 mL. Target step: 2.5 mg. Syringe: U-100, 0.3 mL barrel.

I get a concentration of 10.00 mg/mL from that, which puts my step at a volume I can read on the barrel. What I want checked is the reasoning rather than the division — specifically whether I have chosen the concentration for the right reason.

Nothing to add on the substance. Thank you for taking the question at face value.

Write the reconstitution date and the concentration on the vial. Not on a note, on the vial. Every account here of a dosing error involving the wrong concentration involves a vial with nothing written on it.

Second-hand, so weight it accordingly.

Taking post #3 at face value and following it one step further.

Reconstitution volumes is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty minutes before adding to this one.

Everything in post #3 holds. The case it does not cover is the one I have.

Two people in this thread mean different things by reconstitution volumes and are disagreeing about the definition while believing they are disagreeing about the facts. Worth pausing to define it.

Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile indefinitely, and no supplier claims otherwise.

Agreed on reconstitution volumes, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it does not, and the starting assumption is the part nobody states.

Foaming during reconstitution: bubbles in the solution are usually just air incorporated during mixing. They usually resolve with gentle warming and time. Persistent foam is unusual and might warrant contact with the supplier, but initial foam is ordinary.

I have left out the parts I could not verify.

Noted, and thank you for writing it out rather than summarising it.

The arithmetic in post #7 is right; the assumption feeding it is the part to check.

The best check on any reconstitution calculation is to do it twice by two different routes — mass per volume, then volume per dose — and see whether they agree. They should, and when they do not it is nearly always the concentration step.

That is all the detail I have. Someone else will have more.

I would call the community position on reconstitution volumes likely rather than established, and I would be comfortable defending that hedge.

I read post #10 twice before replying, because I had assumed the opposite.

Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.

The disagreement above is smaller than it looks once the terms are fixed.

Taking post #12 at face value and following it one step further.

The failure mode on reconstitution volumes is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to get wrong.

Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic solutions (close to blood osmolarity) are less irritating than hypertonic solutions. This is why diluent choice (sterile water vs. saline) matters.